NewsletterReceive the most important news of the day by email
BioNTech SE, in partnership with its AI subsidiary InstaDeep, is
revolutionizing immunotherapy by scaling and integrating advanced AI...
12 hours ago
from: TipRanks
- BioNTech unveils AI advancements in immunotherapy LONDON - BioNTech SE (NASDAQ:BNTX), in collaboration with its AI subsidiary
InstaDeep Ltd., has presented an update on its artificial...
from: Investing.com